Global Tech Reporter
SEE OTHER BRANDS

Get your daily news on science and technology

Global Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.

Press releases published on May 23, 2025

Bilibili Inc. Announces Completion of US$690 Million Convertible Senior Notes and Offering of Class Z Ordinary Shares in Connection with Hedging Transactions of Certain Convertible Notes Investors and Terms of Concurrent Repurchase

Bilibili Inc. Announces Completion of US$690 Million Convertible Senior Notes and Offering of Class Z Ordinary Shares in Connection with Hedging Transactions of Certain Convertible Notes Investors and Terms of Concurrent Repurchase

SHANGHAI, May 23, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced (i) the completion of its offering (the “ …

Huize Holding Limited to Report First Quarter 2025 Financial Results on June 6, 2025

Huize Holding Limited to Report First Quarter 2025 Financial Results on June 6, 2025

SHENZHEN, China, May 23, 2025 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data- …

Voting Results from Constellium's 2025 Annual General Meeting

Voting Results from Constellium's 2025 Annual General Meeting

PARIS, May 23, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) announced today that the voting results for its Annual General Meeting of Shareholders held on May 15, 2025 (the “AGM”) have been published on the Company’s website (https://www. …

Hair Growth Supplements Market to be Worth USD 2,581.1 Million by 2032: Coherent Market Insights

Hair Growth Supplements Market to be Worth USD 2,581.1 Million by 2032: Coherent Market Insights

Burlingame, CA, May 23, 2025 (GLOBE NEWSWIRE) -- The global hair growth supplements market was valued at approximately USD 940.1 million in 2025, and this figure is projected to reach around USD 2,581.1 million by 2032, expanding at a robust compound …

VIRTUNE BESCHLEUNIGT EUROPÄISCHE EXPANSION MIT XRP-ETP-DEBÜT AN DER DEUTSCHE BÖRSE XETRA

VIRTUNE BESCHLEUNIGT EUROPÄISCHE EXPANSION MIT XRP-ETP-DEBÜT AN DER DEUTSCHE BÖRSE XETRA

Frankfurt, 23. Mai 2025 – Der schwedische regulierte Krypto-Vermögensverwalter Virtune bringt eines seiner Flaggschiffproduket, den Virtune XRP ETP, an Deutschlands führenden Handelsplatz Deutsche Börse Xetra und erweitert damit sein reguliertes Angebot …

VIRTUNE ACCELERATES EUROPEAN EXPANSION WITH XRP ETP DEBUT ON DEUTSCHE BÖRSE XETRA

VIRTUNE ACCELERATES EUROPEAN EXPANSION WITH XRP ETP DEBUT ON DEUTSCHE BÖRSE XETRA

Frankfurt, 23 May 2025 – Swedish regulated crypto asset manager Virtune brings its flagship Virtune XRP ETP to Germany's premier trading venue Deutsche Börse Xetra, extending its regulated digital asset offerings to Europe's largest economy. With strong …

Music Streaming Market is Expanding Rapidly with 17.3% CAGR by 2032, Driven by On-Demand Audio and Subscription Growth

Music Streaming Market is Expanding Rapidly with 17.3% CAGR by 2032, Driven by On-Demand Audio and Subscription Growth

Burlingame, CA, May 23, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global Music Streaming Market size is calculated at USD 47.06 billion in 2025 and is forecasted to reach around USD 143.89 billion by 2032, …

Inventiva reports 2025 First Quarter Financial Information¹

Inventiva reports 2025 First Quarter Financial Information¹

Cash and cash equivalents at €67.9 million Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral …

Inventiva publie ses informations financières¹ du 1er trimestre 2025

Inventiva publie ses informations financières¹ du 1er trimestre 2025

Trésorerie et équivalents de trésorerie à 67,9 millions d’euros Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans …

Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025

Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025

Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic …

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025

Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …

FRO – First Quarter 2025 Results

FRO – First Quarter 2025 Results

FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three months ended March 31, 2025: Highlights  Profit of $33.3 million, or $ …

Youth sports exchange to bridge cultures, strengthen ties

Youth sports exchange to bridge cultures, strengthen ties

NANJING, China, May 23, 2025 (GLOBE NEWSWIRE) -- The 2025 Belt and Road Youth Sports Exchange Week (Jiangsu) officially launched on Wednesday in Jiangyin, east China's Jiangsu Province, gathering nearly 500 international students from 66 countries and …

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025

OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025 BI 765063 in combination with programmed …

OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours

OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours

OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours sur la modulation de l’immunité innée et l’activité antitumorale via le blocage de SIRPα à l’ASCO 2025 BI …

De Havilland Canada announces the expansion of its presence in Greece

De Havilland Canada announces the expansion of its presence in Greece

ATHENS, Greece, May 23, 2025 (GLOBE NEWSWIRE) -- De Havilland Aircraft of Canada Limited (“De Havilland Canada”) is pleased to announce the launch of De Havilland Aircraft of Canada Hellas Ltd., its new wholly-owned subsidiary in Greece, further …

El servicio nacional Drones como un Servicio (DaaS) de ZenaTech crece con el cierre de su quinta adquisición, sumando capacidades de inspección de líneas eléctricas

El servicio nacional Drones como un Servicio (DaaS) de ZenaTech crece con el cierre de su quinta adquisición, sumando capacidades de inspección de líneas eléctricas

VANCOUVER, Columbia Británica, May 22, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), soluciones …

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of …

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

ROCKVILLE, Md. and SUZHOU, China, May 22, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, today announced that new clinical data from two …

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service